Eili Y. Klein

Publications

22 Jun 2016

How can we model the transmission of Streptococcus pneumoniae for public health and policy, capturing the...

27 May 2015

What is the estimated impact, cost, effectiveness and cost-effectiveness of a an artemisinin combination therapy (ACT) subsidy for malaria treatment targeted at children? How could leakage of the...

22 Jan 2015

Does physician competition drive up antibiotic prescribing? How does the existence of urgent care and retail clinics affect antibiotic prescription rates across different socioeconomic strata?...

2 Apr 2014

In April 2009, a novel human influenza A(H1N1) virus was identified. This virus rapidly spread around the globe causing significant morbidity and mortality in 2009/10. This virus was of swine...

6 Jan 2014

How does heterogeneous transmission affect the spread of antimalarial drug resistance?

28 Feb 2014

How prevalent is S. epidermis, the most common Coagulase-negative staphylococci (CoNS) pathogen, and what are trends in its resistance profile? How does this compare to all...

27 Feb 2013

Will community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) coexist...

27 Feb 2013

How has the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) changed in recent years?

7 Feb 2013

This article examines what is known about how resistance to antimalarial drugs emerges and spreads, and reviews various strategies for controlling the spread of resistance.

22 Jan 2013

What is the national epidemiology of Klebsiella pneumoniae isolates resistant to carbapenems (CRKP) and third-generation cephalosporins (G3CRKP)? 

...